Skip to content

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Menu

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Search

Search

Close this search box.

dMed Biopharmaceutical

Healthcare

Vivo Capital Leads $50M Series B Round In Chinese CRO Firm dMed Biopharmaceutical

October 16, 2019 — 17:50

Home
About Us
Contact Us
Privacy
Terms & Conditions

Menu

Home
About Us
Contact Us
Privacy
Terms & Conditions

© 2024 China Money Network. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.